The European Commission is getting ready to review citizens’ proposals and one controversial idea on the table is the ‘PsychedeliCare’ initiative that supports the exploration and implementation of psychedelic treatments for mental wellbeing issues. Advocates of this initiative highlight the advantages of using psychedelics in addressing mental health concerns; however it’s crucial to carefully assess the consequences of making these substances mainstream for therapeutic use, it already happened with way too many “pharma products” and end up being dangerous street drugs, as this is what they actually were from the beginning.
The Illusory Promise of Psychedelics
Supporters of this “therapies” frequently promote these substances as amazing remedies for profound mental health challenges like depression and anxiety disorders such as PTSD are regularly highlighted by them in support of their claims. However, these early research findings are willfully misinterpreted and exaggerated. The “positive outcomes” observed in limited research studies do not automatically translate to safety and effectiveness across wider and more varied demographic groups, often the contrary. Throughout history the fascination with a quick fix for mental health issues has often resulted in disappointment and harm, if not death.
A Lack of Comprehensive Understanding
The insufficient scientific knowledge about psychedelics raises concerns within the community as the intricate workings of the human brain remain a mystery when influenced by these substances. There are risks such as psychological distress and worsening of preexisting mental health conditions that make it unthinkable to integrate psychedelics into mainstream therapy practices at all. It is crucial to acknowledge the variations in individual experiences and biological compositions to prevent unintended harm rather than aiding in treatment efforts.
Regulatory and Ethical Concerns
The push for government endorsement of psychedelic therapies raises numerous ethical questions. Should substances with known ps